Drug intelligence / Profile preview

DA + CPT-KK

Development stage
Preclinical
Modality
Small Molecules, Peptide-Drug Conjugates → Peptide Conjugates → Peptides, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

DA + CPT-KK is a modular, nanoscale drug delivery platform composed of camptothecin (CPT) conjugated to a dilysine (KK) peptide, which self-assembles into nanotubes. These nanotubes are further stabilized by a layer of polydopamine (DA/PDA). The system is designed to deliver camptothecin, a potent DNA topoisomerase I inhibitor, to cancer cells. The polydopamine coating provides structural stability and serves as a versatile surface for the attachment of targeting moieties, such as antibody fragments. In preclinical studies, this platform has demonstrated enhanced cytotoxicity against TAG-72-expressing colon cancer cells when functionalized with specific targeting ligands like anti-TAG-72 scFv.

Other names
polydopamine-stabilized camptothecin-dilysine nanotubeCPT-dilysine nanotube stabilized with polydopamine
02

Targets

TAG-72TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on DA + CPT-KK.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DA + CPT-KK.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call